Diabetes and CKD: Strategies for Diagnosis and Treatment
May 21, 2024 - 00:11:00
Radio and PodcastLive Radio & PodcastsScience & Medicine
Discussing a T2D Medication That Could Reduce Insulin Needs in T1D
Host: Mary Katherine Cheeley, PharmD, BCPS, CLS, FNLA Guest: David Selzer, MD New research suggests that a GLP-1 receptor agonist medication, semaglutide, which has been approved for type 2 diabetes and obesity, could al...
About This Episode
Discussing a T2D Medication That Could Reduce Insulin Needs in T1D is an episode from Diabetes Discourse by ReachMD. Host: Mary Katherine Cheeley, PharmD, BCPS, CLS, FNLA Guest: David Selzer, MD New research suggests that a GLP-1 receptor a...
Podcast
This episode belongs to Diabetes Discourse.
Listen Online
Use the player on this page to stream the episode online.
Episode Details
Published Nov 27, 2023, 00:11:30 long, audio available.
Related Episodes
Continue listening to more episodes from Diabetes Discourse.
Uncovering the Prevalence of Type 1 Diabetes in Older Adults
May 9, 2024 - 00:07:30
Concentrating on the MOMPOD Trial for Metformin Plus Insulin
Apr 12, 2024 - 00:10:30
Utilizing Hybrid Closed-Loop Technology for T1D Pediatric Patients
Apr 9, 2024 - 00:07:00
Semaglutide Reduces CV Events in Non-Diabetic, Overweight Patients
Apr 8, 2024 - 00:11:30
Overcoming Obesity: Insights from the SURMOUNT-4 Trial
Mar 27, 2024 - 00:12:30
Strategies for Addressing Diabetes Stigma and Discrimination
Feb 1, 2024 - 00:11:00
How the Artificial Pancreas Can Help Diabetic Patients
Dec 20, 2023 - 00:03:00